Taken together, we propose that tumor-released circulating activin A remotely suppresses the expression of PGC1α in muscle endothelium and results in endothelial dysfunction by increasing EC death, vascular leakiness and EndMT, thereby causing cachexic muscles (Fig. 8m). Here, PPARGC1A is linked to endothelial dysfunction.